Literature DB >> 33253120

Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats.

Peng Li1,2, Xiaojun Li1, Peng Deng1, Dandan Wang1, Xuehong Bai1, Yujie Li1, Chunxia Luo3, Karine Belguise4, Xiaobo Wang4, Xinchuan Wei2, Zhengyuan Xia5,6, Bin Yi1.   

Abstract

The incidence of subarachnoid hemorrhage (SAH) and hazard ratio of death increase with age. Overactivation of microglia contributes to brain damage. This study aimed to investigate the effects of A3 adenosine receptors (A3R) activation on neurofunction and microglial phenotype polarization in the context of SAH in aged rats. The A3R agonist (CI-IB-MECA) and antagonist (MRS1523) were used in the SAH model. Microglia were cultured to mimic SAH in the presence or absence of CI-IB-MECA and/or siRNA for A3R. The neurofunction and status of the microglial phenotype were evaluated. The P38 inhibitor SB202190 and the STAT6 inhibitor AS1517499 were used to explore the signaling pathway. The results showed that SAH induced microglia to polarize to the M(LPS) phenotype both in vivo and in vitro. CI-IB-MECA distinctly skewed microglia towards the M(IL-4) phenotype and ameliorated neurological dysfunction, along with the downregulation of inflammatory cytokines. Knockdown of A3R or inhibition of P38 and/or STAT6 weakened the effects of CI-IB-MECA on microglial phenotypic shifting. Collectively, our findings suggest that activation of A3R exerted anti-inflammatory and neuroprotective effects by regulating microglial phenotype polarization through P38/STAT6 pathway and indicated that A3R agonists may be a promising therapeutic options for the treatment of brain injury after SAH.

Entities:  

Keywords:  adenosine A3 receptor; anti-inflammation; microglial polarization; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2020        PMID: 33253120      PMCID: PMC7835045          DOI: 10.18632/aging.202178

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  67 in total

Review 1.  Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.

Authors:  Tuan Leng Tay; Julie C Savage; Chin Wai Hui; Kanchan Bisht; Marie-Ève Tremblay
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

2.  Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice.

Authors:  Shuhei Kobashi; Tomoya Terashima; Miwako Katagi; Yuki Nakae; Junko Okano; Yoshihisa Suzuki; Makoto Urushitani; Hideto Kojima
Journal:  Mol Ther       Date:  2019-09-10       Impact factor: 11.454

Review 3.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

4.  Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages.

Authors:  Emilie Velot; Benjamin Haas; Frédérique Léonard; Isabelle Ernens; Magali Rolland-Turner; Chantal Schwartz; Dan Longrois; Yvan Devaux; Daniel R Wagner
Journal:  Cardiovasc Res       Date:  2008-07-24       Impact factor: 10.787

5.  Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.

Authors:  Shanwu Wei; Chunxia Luo; Shanping Yu; Jin Gao; Chang Liu; Zheng Wei; Zhiren Zhang; Ling Wei; Bin Yi
Journal:  Exp Cell Res       Date:  2017-11-02       Impact factor: 3.905

6.  Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.

Authors:  Avivit Ochaion; Sara Bar-Yehuda; Shira Cohn; Luis Del Valle; Georginia Perez-Liz; Lea Madi; Faina Barer; Motti Farbstein; Sari Fishman-Furman; Tatiana Reitblat; Alexander Reitblat; Howard Amital; Yair Levi; Yair Molad; Reuven Mader; Moshe Tishler; Pnina Langevitz; Alexander Zabutti; Pnina Fishman
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation.

Authors:  Clotilde Lauro; Myriam Catalano; Eleonora Di Paolo; Giuseppina Chece; Ida de Costanzo; Flavia Trettel; Cristina Limatola
Journal:  Front Cell Neurosci       Date:  2015-01-21       Impact factor: 5.505

8.  Glucose transporter 1 critically controls microglial activation through facilitating glycolysis.

Authors:  Luxi Wang; Sofia Pavlou; Xuan Du; Mohajeet Bhuckory; Heping Xu; Mei Chen
Journal:  Mol Neurodegener       Date:  2019-01-11       Impact factor: 14.195

Review 9.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

Authors:  Jonathan D Cherry; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroinflammation       Date:  2014-06-03       Impact factor: 8.322

Review 10.  Microglial subtypes: diversity within the microglial community.

Authors:  Vassilis Stratoulias; Jose Luis Venero; Marie-Ève Tremblay; Bertrand Joseph
Journal:  EMBO J       Date:  2019-08-02       Impact factor: 11.598

View more
  9 in total

1.  Apelin-13 attenuates early brain injury through inhibiting inflammation and apoptosis in rats after experimental subarachnoid hemorrhage.

Authors:  Xiaoyan Shen; Guiqiang Yuan; Bing Li; Cheng Cao; Demao Cao; Jiang Wu; Xiang Li; Haiying Li; Haitao Shen; Zhong Wang; Gang Chen
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316

2.  A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity.

Authors:  Dilip K Tosh; Veronica Salmaso; Ryan G Campbell; Harsha Rao; Amelia Bitant; Eline Pottie; Christophe P Stove; Naili Liu; Oksana Gavrilova; Zhan-Guo Gao; John A Auchampach; Kenneth A Jacobson
Journal:  Eur J Med Chem       Date:  2021-11-19       Impact factor: 6.514

3.  The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.

Authors:  Pedro Valada; Sonja Hinz; Christin Vielmuth; Cátia R Lopes; Rodrigo A Cunha; Christa E Müller; João Pedro Lopes
Journal:  Purinergic Signal       Date:  2022-09-26       Impact factor: 3.950

4.  Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.

Authors:  R Rama Suresh; Zhan-Guo Gao; Veronica Salmaso; Eric Chen; Ryan G Campbell; Russell B Poe; Theodore E Liston; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2022-03-02       Impact factor: 4.632

5.  Pharmaceutical Management for Subarachnoid Hemorrhage.

Authors:  Arnav Barpujari; Chhaya Patel; Rebecca Zelmonovich; Alec Clark; Devan Patel; Kevin Pierre; Kyle Scott; Brandon Lucke Wold
Journal:  Recent Trends Pharm Sci Res       Date:  2021

6.  Protective mechanism of FoxO1 against early brain injury after subarachnoid hemorrhage by regulating autophagy.

Authors:  Haitao Hao; Yahui Bai; Yu Liu; Junxin Liang; Shichao Guo
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

Review 7.  The role of the astrocyte in subarachnoid hemorrhage and its therapeutic implications.

Authors:  Rong Li; Min Zhao; Di Yao; Xiangyue Zhou; Cameron Lenahan; Ling Wang; Yibo Ou; Yue He
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

Review 8.  Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).

Authors:  Judith Weiland; Alexandra Beez; Thomas Westermaier; Ekkehard Kunze; Anna-Leena Sirén; Nadine Lilla
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 9.  Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?

Authors:  Stefania Merighi; Tino Emanuele Poloni; Anna Terrazzan; Eva Moretti; Stefania Gessi; Davide Ferrari
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.